The Board of Directors of Jeil Pharmaceutical Co., Ltd. has authorized a buyback plan on August 28, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,550 KRW | +2.03% | -0.85% | -10.37% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-10.37% | 119M | |
+16.98% | 42.25B | |
+15.31% | 21.27B | |
+19.33% | 15.23B | |
+19.05% | 14.36B | |
+50.37% | 12.74B | |
-0.05% | 6.79B | |
-12.12% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.